SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-015646
Filing Date
2021-06-30
Accepted
2021-06-30 09:30:20
Documents
15
Period of Report
2021-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 51152
2 ex10-1.htm EX-10.1 178957
3 ex10-2.htm EX-10.2 295461
4 ex10-3.htm EX-10.3 216871
5 ex10-4.htm EX-10.4 83562
6 ex10-5.htm EX-10.5 65628
7 ex10-6.htm EX-10.6 178024
8 ex10-7.htm EX-10.7 97356
9 ex10-8.htm EX-10.8 42244
10 ex99-1.htm EX-99.1 16769
11 ex10-6_001.jpg GRAPHIC 23595
12 ex10-6_002.jpg GRAPHIC 30873
13 ex10-6_003.jpg GRAPHIC 78017
14 ex10-6_004.jpg GRAPHIC 31933
15 ex99-1_001.jpg GRAPHIC 59993
  Complete submission text file 0001493152-21-015646.txt   1536909
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 211060590
SIC: 3841 Surgical & Medical Instruments & Apparatus